(4S,7R)-7,8,8-TRIMETHYL-4,5,6,7-TETRAHYDRO-4,7-METHANO-2-H-INDAZOLE-2-CARBOXAMIDE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | AUlpR0dY386 |
|---|---|
| InChI | InChI=1S/C12H17N3O/c1-11(2)8-4-5-12(11,3)9-7(8)6-15(14-9)10(13)16/h6,8H,4-5H2,1-3H3,(H2,13,16)/t8-,12+/m0/s1 |
| InChIKey | XHJOFVYQTXMCAG-QPUJVOFHSA-N |
| Mol Weight | 219.29 g/mol |
| Molecular Formula | C12H17N3O |
| Exact Mass | 219.137162 g/mol |
| Enantiomer InChIKey | XHJOFVYQTXMCAG-PELKAZGASA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(4S,7R)-2-(DIETHYLAMINO)-7,8,8-TRIMETHYL-4,5,6,7-TETRAHYDRO-4,7-METHANO-2-H-INDAZOLE
1-(CAMPHOPYRAZOL-2-YL)-2-(PYRAZOL-1-YL)-ETHANE
Ethyl(4S,7R)-7,8,8-Trimethyl-4,5,6,7-tetrahydro-4,7-methano-2-indazloylacetate
(4S,7R)-7,8,8-TRIMETHYL-2-(PYRIMIDIN-2-YL)-4,5,6,7-TETRAHYDRO-4,7-METHANO-2-H-INDAZOLE
2,2'-BIS-[(5S,8R)-8,9,9-TRIMETHYL-5,6,7,8-TETRAHYDRO-5,8-METHANOQUINAZOLINE]
N-(2-chlorobenzyl)-5-(1-[2-(3,4-dimethylanilino)-2-oxoethyl]-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)pentanamide
14-Ethyl-7-methyl-6,7,8,9,14,15-hexahydro-5H-indolo-[3,2-f][3]benzazecine
Indolo[2,3-a]quinolizine-2-ethanol, .beta.-ethyl-1,2,3,4,6,7,12,12b-octahydro-, acetate (ester), [2S-[2.alpha.(S*),12b.alpha.]]-
4-(1-[2-(4-bromo-2-fluoroanilino)-2-oxoethyl]-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)-N-(4-methylbenzyl)butanamide
5-(1-[2-(4-bromo-2-fluoroanilino)-2-oxoethyl]-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)-N-(2-furylmethyl)pentanamide
| Title | Journal or Book | Year |
|---|---|---|
| Chiral Heterocyclic Ligands. VIII. Syntheses and Complexes of New Chelating Ligands Derived From Camphor | Australian Journal of Chemistry | 1995 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.